Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−16.40 USD
−11.39 M USD
8.68 M USD
659.64 K
About ReShape Lifesciences, Inc.
Sector
Industry
CEO
Paul F. Hickey
Website
Headquarters
San Clemente
Founded
2002
FIGI
BBG0036S6JY0
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RSLS is 5.58 USD — it has increased by 10.71% in the past 24 hours. Watch ReShape Lifesciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ReShape Lifesciences, Inc. stocks are traded under the ticker RSLS.
RSLS stock has risen by 5.28% compared to the previous week, the month change is a −17.58% fall, over the last year ReShape Lifesciences, Inc. has showed a −53.30% decrease.
RSLS reached its all-time high on Oct 6, 2016 with the price of 1,381,557.66 USD, and its all-time low was 4.60 USD and was reached on Oct 4, 2024. View more price dynamics on RSLS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RSLS stock is 16.47% volatile and has beta coefficient of 1.20. Track ReShape Lifesciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is ReShape Lifesciences, Inc. there?
Today ReShape Lifesciences, Inc. has the market capitalization of 3.98 M, it has decreased by −2.51% over the last week.
Yes, you can track ReShape Lifesciences, Inc. financials in yearly and quarterly reports right on TradingView.
ReShape Lifesciences, Inc. is going to release the next earnings report on Mar 31, 2025. Keep track of upcoming events with our Earnings Calendar.
RSLS earnings for the last quarter are −3.02 USD per share, whereas the estimation was −5.80 USD resulting in a 47.87% surprise. The estimated earnings for the next quarter are −4.06 USD per share. See more details about ReShape Lifesciences, Inc. earnings.
ReShape Lifesciences, Inc. revenue for the last quarter amounts to 2.29 M USD, despite the estimated figure of 2.51 M USD. In the next quarter, revenue is expected to reach 3.17 M USD.
RSLS net income for the last quarter is −1.58 M USD, while the quarter before that showed −1.59 M USD of net income which accounts for 0.88% change. Track more ReShape Lifesciences, Inc. financial stats to get the full picture.
No, RSLS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 31.00 employees. See our rating of the largest employees — is ReShape Lifesciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ReShape Lifesciences, Inc. EBITDA is −7.89 M USD, and current EBITDA margin is −166.92%. See more stats in ReShape Lifesciences, Inc. financial statements.
Like other stocks, RSLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ReShape Lifesciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ReShape Lifesciences, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ReShape Lifesciences, Inc. stock shows the sell signal. See more of ReShape Lifesciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.